Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page
- CheckyesterdayChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version for internal tracking.SummaryDifference0.0%

- Check8 days agoChange DetectedUT MD Anderson Cancer Center was added as a participating site in the study record (dated 2026-07-15/16). The prior entry for MD Anderson Cancer Center, listed as 'M D Anderson Cancer Center', was removed (dated 2026-04-16/21).SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange Detected- The page revision was updated from v3.6.2 to v3.6.3. This update reflects a version change and does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the site's template or content management without altering the study content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page adds a recruitment-closed notice and new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment header is updated and the revision version is changed to v3.6.0.SummaryDifference0.2%

- Check51 days agoChange DetectedFooter text now shows Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a version tag update for the page rather than a change to study content.SummaryDifference0.0%

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.